ASND vs. TEM: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ASND and TEM, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
With ASND at 9.55 billion USD and TEM at 9.77 billion USD, their market capitalizations sit in the same ballpark.
TEM carries a higher beta at 7.68, indicating it’s more sensitive to market moves, while ASND remains steadier at 0.40.
ASND trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while TEM remains a standard domestic listing.
Symbol | ASND | TEM |
---|---|---|
Company Name | Ascendis Pharma A/S | Tempus AI, Inc. |
Country | DK | US |
Sector | Healthcare | Healthcare |
Industry | Biotechnology | Medical - Diagnostics & Research |
CEO | Mr. Jan Moller Mikkelsen | Mr. Eric P. Lefkofsky |
Price | 158.1 USD | 58.14 USD |
Market Cap | 9.55 billion USD | 9.77 billion USD |
Beta | 0.40 | 7.68 |
Exchange | NASDAQ | NASDAQ |
IPO Date | January 28, 2015 | March 28, 2012 |
ADR | Yes | No |
Performance Comparison
This chart compares the performance of ASND and TEM over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ASND and TEM based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- Neither ASND nor TEM turned a profit—both carry negative P/E ratios of -24.55 and -13.98, underscoring continued losses that pressure their valuations.
- ASND posts a negative forward PEG of -2.23, hinting at anticipated earnings decline, whereas TEM at 0.14 has projections for stable or growing earnings.
- ASND has a negative P/B ratio of -44.19, indicating its liabilities exceed assets (negative equity). TEM, with a P/B of 30.39, maintains positive shareholder equity.
- ASND and TEM both consumed more free cash flow than they generated last year—P/FCF of -27.43 and -45.95, respectively—highlighting persistent liquidity pressure.
Symbol | ASND | TEM |
---|---|---|
Price-to-Earnings Ratio (P/E, TTM) | -24.55 | -13.98 |
Forward PEG Ratio (TTM) | -2.23 | 0.14 |
Price-to-Sales Ratio (P/S, TTM) | 22.88 | 12.16 |
Price-to-Book Ratio (P/B, TTM) | -44.19 | 30.39 |
Price-to-Free Cash Flow Ratio (P/FCF, TTM) | -27.43 | -45.95 |
EV-to-EBITDA (TTM) | -35.74 | -16.45 |
EV-to-Sales (TTM) | 23.78 | 13.04 |
EV-to-Free Cash Flow (TTM) | -28.50 | -49.27 |
Dividend Comparison
Neither ASND nor TEM currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
Symbol | ASND | TEM |
---|---|---|
Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ASND and TEM, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ASND’s quick ratio of 0.71 suggests it may struggle to cover immediate liabilities without selling inventory or raising cash, whereas TEM at 1.56 maintains a comfortable buffer of liquid assets.
- ASND has negative equity (debt-to-equity ratio -4.46), an unusual warning sign, while TEM at 2.63 maintains a conventional debt-to-equity balance.
- Both ASND and TEM report negative interest coverage ratios (-3.72, -12.09), meaning EBIT itself is negative—neither can cover interest, a critical solvency warning.
Symbol | ASND | TEM |
---|---|---|
Current Ratio (TTM) | 1.04 | 1.71 |
Quick Ratio (TTM) | 0.71 | 1.56 |
Debt-to-Equity Ratio (TTM) | -4.46 | 2.63 |
Debt-to-Assets Ratio (TTM) | 0.80 | 0.56 |
Interest Coverage Ratio (TTM) | -3.72 | -12.09 |